We are live on
!
Find out more
DIM
DC Investments Management Portfolio holdings
AUM
$261M
1-Year Est. Return
20.71%
This Fund
S&P 500
This Quarter
Est. Return
+3.69%
1 Year Est. Return
+20.71%
3 Year Est. Return
+44.71%
5 Year Est. Return
+36.74%
10 Year Est. Return
–
AUM
$157M
AUM Growth
+$8.18M
(+5.5%)
Cap. Flow
+$6.12M
Cap. Flow
% of AUM
3.89%
Top 10 Holdings %
Top 10 Hldgs %
6.71%
Holding
424
New
174
Increased
42
Reduced
68
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Evergy
EVRG
|
+$1.09M |
| 2 |
AerCap
AER
|
+$863K |
| 3 |
GRMN
Garmin
GRMN
|
+$838K |
| 4 |
GSK
GSK
|
+$820K |
| 5 |
SF
Stifel
SF
|
+$818K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.51M |
| 2 |
Amgen
AMGN
|
+$2.11M |
| 3 |
Johnson & Johnson
JNJ
|
+$1.68M |
| 4 |
Northrop Grumman
NOC
|
+$1.55M |
| 5 |
Becton Dickinson
BDX
|
+$1.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.87% |
| 2 | Financials | 19.67% |
| 3 | Technology | 12.25% |
| 4 | Real Estate | 10.82% |
| 5 | Utilities | 10.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Verizon
VZ
$195B
| $562K | 0.36% |
11,162
-7,339
| -40% | -$355K |
|
|
AET
102
DELISTED
Aetna Inc
AET
| $562K | 0.36% |
3,060
-3,981
| -57% | -$710K |
|
|
RWT
103
Redwood Trust
RWT
$589M
| $561K | 0.36% |
+34,086
| New | +$547K |
|
104
W.P. Carey
WPC
$16.5B
| $561K | 0.36% |
+8,632
| New | +$547K |
|
105
Ameren
AEE
$30.3B
| $560K | 0.36% |
9,206
-8,590
| -48% | -$494K |
|
106
Portland General Electric
POR
$5.89B
| $560K | 0.36% |
13,094
-437
| -3% | -$18K |
|
107
NorthWestern Energy
NWE
$4.3B
| $559K | 0.36% |
9,766
+5,001
| +105% | +$271K |
|
108
Northwest Bancshares
NWBI
$2.34B
| $559K | 0.36% |
+32,130
| New | +$548K |
|
109
Capitol Federal Financial
CFFN
$1.13B
| $558K | 0.35% |
+42,438
| New | +$550K |
|
110
Dianthus Therapeutics
DNTH
$6.04B
| $558K | 0.35% |
+2,583
| New | +$583K |
|
111
Elevance Health
ELV
$82B
| $558K | 0.35% |
2,346
-6,542
| -74% | -$1.51M |
|
112
Gaming and Leisure Properties
GLPI
$12.6B
| $558K | 0.35% |
15,596
-752
| -5% | -$26.1K |
|
113
HCA Healthcare
HCA
$86.8B
| $557K | 0.35% |
+5,430
| New | +$549K |
|
114
Idacorp
IDA
$8.36B
| $556K | 0.35% |
6,032
-5,718
| -49% | -$513K |
|
115
Brady Corp
BRC
$4.6B
| $554K | 0.35% |
+14,370
| New | +$552K |
|
|
CIM
116
Chimera Investment
CIM
$1.06B
| $552K | 0.35% |
+10,060
| New | +$543K |
|
|
FISV
117
Fiserv Inc
FISV
$29.7B
| $552K | 0.35% |
7,446
-7,692
| -51% | -$559K |
|
|
WGL
118
DELISTED
Wgl Holdings
WGL
| $552K | 0.35% |
6,216
-5,932
| -49% | -$516K |
|
119
CMS Energy
CMS
$22.5B
| $551K | 0.35% |
11,660
-9,916
| -46% | -$448K |
|
|
PMT
120
PennyMac Mortgage Investment
PMT
$831M
| $551K | 0.35% |
29,016
-5,552
| -16% | -$102K |
|
121
Walt Disney
DIS
$170B
| $550K | 0.35% |
5,244
+2,475
| +89% | +$253K |
|
122
Hercules Capital
HTGC
$3.16B
| $550K | 0.35% |
+43,506
| New | +$538K |
|
|
TECX
123
Tectonic Therapeutic
TECX
$550M
| $549K | 0.35% |
+1,603
| New | +$578K |
|
124
Amphenol
APH
$211B
| $548K | 0.35% |
25,136
-28,436
| -53% | -$619K |
|
125
Brookfield
BN
$109B
| $548K | 0.35% |
+37,854
| New | +$540K |
|
Similar funds
DC
AFC
TIG
NG
ICM
TSW
ACM
ASP
DC Investments Management's Q2 2018 Portfolio in Review
As of Q2 2018, DC Investments Management held 424 positions worth $157M, up 5.5% from $149M the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
DC Investments Management deployed $6.12M of net new capital in Q2 2018, opening 174 new positions and adding to 42 existing holdings. Its largest new stake was Evergy: 20,319 shares worth $1.14M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Pfizer, an estimated $2.51M trimmed.
- DC Investments Management's largest Q2 2018 buy was Evergy: 20,319 shares worth $1.14M.
- DC Investments Management added most to TotalEnergies in Q2 2018, an estimated $612K increase.
- DC Investments Management's biggest Q2 2018 reduction was Pfizer, cutting an estimated $2.51M.
- DC Investments Management fully exited Amgen in Q2 2018, selling an estimated $2.11M.
- DC Investments Management's ten largest holdings make up 6.7% of its $157M portfolio in Q2 2018.
- DC Investments Management opened 174 new positions and closed 139 in Q2 2018.
- DC Investments Management's portfolio value rose 5.5% quarter-over-quarter to $157M.
Based on DC Investments Management's 13F filing for Q2 2018, filed 3 Aug 2018.